Clinical Study Results
Research Sponsor: MedImmune LLC
Drug Studied: MEDI7247
Study Title: A study to learn about the safety of MEDI7247
in participants with advanced or metastatic solid tumors
Thank you!
Thank you for taking part in the clinical study for the study drug MEDI7247.
MedImmune sponsored this study and believes it is important to share the results.
An independent non-profit organization called CISCRP helped prepare this summary of the study results for you.
If you participated in the study and have questions about the results, please speak with the study doctor or staff at your study site.